Targeting DNA junction sites by bis-intercalators induces topological changes with potent antitumor effects

Area of Science:

• Molecular Biology
• Medicinal Chemistry
• Biophysics

Background:

• Targeting DNA structures like inter-duplex junctions is a strategy for anticancer drug development.
• Bis-intercalators offer a potential mechanism for interacting with and modifying these DNA structures.

Purpose of the Study:

• To investigate the interaction of novel bis-intercalators (DA4 and DA5) with a model DNA tetraplex junction.
• To elucidate the structural changes induced by these bis-intercalators and their impact on DNA topology.
• To explore the potential anticancer mechanisms, including enzyme inhibition.

Main Methods:

• Synthesis and characterization of alkyl-linked diaminoacridine bis-intercalators DA4 and DA5.
• Utilizing d(CGTATACG)2 as a model DNA tetraplex junction.
• Structural analysis of DNA-bis-intercalator complexes using biophysical techniques.
• Assessing the inhibition of topoisomerase 2 activity.

Main Results:

• Bis-intercalators DA4 and DA5 induced significant structural changes in the DNA junction, transitioning it to an over-wound, side-by-side inter-duplex conformation with A-DNA characteristics.
• The bis-intercalators intercalated into adjacent duplexes with propeller geometry, with DA5 showing specific interactions with CpG sites.
• The observed topological changes correlated with the inhibition of topoisomerase 2 activity.

Conclusions:

• Bis-intercalators can effectively target and remodel DNA-DNA contact structures.
• Structural modifications induced by DA4 and DA5, including topoisomerase 2 inhibition, provide a basis for their potential anticancer effects.
• This study provides a foundation for developing bis-intercalators that target DNA structures for novel cancer therapies.